Nishadil
Signup Signin
Delhi | 25°C (windy)
Major Clinical Setback: Harmony Biosciences' Genetic Disorder Drug Disappoints in Crucial Phase 3 Study

Major Clinical Setback: Harmony Biosciences' Genetic Disorder Drug Disappoints in Crucial Phase 3 Study
A Crushing Blow: Acadia Pharma's Prader-Willi Syndrome Trial Fails to Meet Endpoints

A Crushing Blow: Acadia Pharma's Prader-Willi Syndrome Trial Fails to Meet Endpoints
Tragic Loss in Vyfat XR Trial Casts Shadow on Soleno Therapeutics

Tragic Loss in Vyfat XR Trial Casts Shadow on Soleno Therapeutics
Talphaera's Q2 2025: Unpacking Financials & Pioneering Biotech Advancements

Talphaera's Q2 2025: Unpacking Financials & Pioneering Biotech Advancements
Load more..